Dragon Pharmaceuticals Inc. (OTC BB – DRUG.OB) is pleased to announce that it has been invited to present at the BioPartnering Europe 2001 conference to be held at the Queen Elizabeth II Conference Centre in London, England from October 14th to 16th, 2001.
BioPartnering Europe is the premier European venue for showcasing innovative biopharmaceutical and diagnostics companies from Europe, North America, and the rest of the world. The conference focuses on the development of corporate partnerships for both biotechnology and pharmaceutical companies.
Dragon will be participating at the conference with the goal of meeting with potential pharmaceutical industry partners for the marketing and co-development of the Company’s products, including EPO, Slow-Release EPO, TPO, G-CSF, Human Insulin and Hepatitis B Vaccine.
